可调钠透析联合米多君治疗对透析低血压的疗效观察(2)
![]() |
第1页 |
参见附件。
参考文献:
[1]白霞凤.低温联合可调钠治疗模式对老年透析低血压的疗效观察[J].世界中西医结合杂志,2010,5(7):616-618.
[2]Kooman, Basci A, Pizzarelli F, et al. EBPG guideline on haemodynamic instability[J].Nephrol Dial Transplant,2007,22 suppl 2:22-44.
[3]杨建新,胡志娟.低温可调钠透析联合参麦注射液预防血透相关性低血压临床观察[J].浙江中西医结合杂志,2012,22(9):703-704.
[4]Daugirdas JT, Blake PG, Todd S. Handbook of dialysis [M]. Hagerstown,MD. 3rd ed. L ippincott Williams & Wilkins,2001.
[5]Pmer BF, Henich WL. Recent advances in the prevention and management of intradialytic hypotension[J].Am Soc Nephrol, 2008 ,19:8-11.
[6]Shoji T, Tsubakihara Y, Fujii M, et al. Hemodialysisassociated hypotension as an independent risk factor for two-year mortality in hemodialysis patients[J]. Kidney Int, 2004, 66: 1212-1220.
[7]常永丽,石东英,武素珍.低温可调钠配合超滤模式预防透析低血压[J].内蒙古医学院学报,2012,34(5):779-781.
[8]刘虹,刘伏友,彭佑铭,等.可调钠血液透析对透析低血压的预防作用[J].中国血液净化,2002,1(8):21-23.
[9]戎殳,梅长林,郭志勇,等.盐酸米多君治疗血液透析中低血压的多中心开放研究[J].中华肾脏病杂志,2008,4:231-234.
[10]Prakash S, Garg AX, Heidenheim AP, et al. Midodrine appears to be safe and effective for dialysis-indueed hypotension: a systematic review [J]. Nephrol Dial Transplant, 2004, 19: 2553-2558.
编辑/申磊
您现在查看是摘要介绍页,详见PDF附件。